Cargando…

Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia

Fibromyalgia (FM) is a chronic and highly disabling syndrome, which is still underdiagnosed, with controversial treatment. Although its aetiology is unknown, a number of studies have pointed to the involvement of altered mitochondrial metabolism, increased oxidative stress and inflammation. The inta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramírez-Tejero, Jorge A., Martínez-Lara, Esther, Peinado, M Ángeles, del Moral, María Luisa, Siles, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468876/
https://www.ncbi.nlm.nih.gov/pubmed/32784915
http://dx.doi.org/10.3390/nu12082386
_version_ 1783578307474751488
author Ramírez-Tejero, Jorge A.
Martínez-Lara, Esther
Peinado, M Ángeles
del Moral, María Luisa
Siles, Eva
author_facet Ramírez-Tejero, Jorge A.
Martínez-Lara, Esther
Peinado, M Ángeles
del Moral, María Luisa
Siles, Eva
author_sort Ramírez-Tejero, Jorge A.
collection PubMed
description Fibromyalgia (FM) is a chronic and highly disabling syndrome, which is still underdiagnosed, with controversial treatment. Although its aetiology is unknown, a number of studies have pointed to the involvement of altered mitochondrial metabolism, increased oxidative stress and inflammation. The intake of extra virgin olive oil, and particularly of one of its phenolic compounds, hydroxytyrosol (HT), has proven to be protective in terms of redox homeostatic balance and the reduction of inflammation. In this context, using a proteomic approach with nanoscale liquid chromatography coupled to tandem mass spectrometry, the present study analysed: (i) Changes in the proteome of dermal fibroblasts from a patient with FM versus a healthy control, and (ii) the effect of the treatment with a nutritional relevant dose of HT. Our results unveiled that fibroblast from FM show a differential expression in proteins involved in the turnover of extracellular matrix and oxidative metabolism that could explain the inflammatory status of these patients. Moreover, a number of these proteins results normalized by the treatment with HT. In conclusion, our results support that an HT-enriched diet could be highly beneficial in the management of FM.
format Online
Article
Text
id pubmed-7468876
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74688762020-09-04 Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia Ramírez-Tejero, Jorge A. Martínez-Lara, Esther Peinado, M Ángeles del Moral, María Luisa Siles, Eva Nutrients Article Fibromyalgia (FM) is a chronic and highly disabling syndrome, which is still underdiagnosed, with controversial treatment. Although its aetiology is unknown, a number of studies have pointed to the involvement of altered mitochondrial metabolism, increased oxidative stress and inflammation. The intake of extra virgin olive oil, and particularly of one of its phenolic compounds, hydroxytyrosol (HT), has proven to be protective in terms of redox homeostatic balance and the reduction of inflammation. In this context, using a proteomic approach with nanoscale liquid chromatography coupled to tandem mass spectrometry, the present study analysed: (i) Changes in the proteome of dermal fibroblasts from a patient with FM versus a healthy control, and (ii) the effect of the treatment with a nutritional relevant dose of HT. Our results unveiled that fibroblast from FM show a differential expression in proteins involved in the turnover of extracellular matrix and oxidative metabolism that could explain the inflammatory status of these patients. Moreover, a number of these proteins results normalized by the treatment with HT. In conclusion, our results support that an HT-enriched diet could be highly beneficial in the management of FM. MDPI 2020-08-09 /pmc/articles/PMC7468876/ /pubmed/32784915 http://dx.doi.org/10.3390/nu12082386 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ramírez-Tejero, Jorge A.
Martínez-Lara, Esther
Peinado, M Ángeles
del Moral, María Luisa
Siles, Eva
Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia
title Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia
title_full Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia
title_fullStr Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia
title_full_unstemmed Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia
title_short Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia
title_sort hydroxytyrosol as a promising ally in the treatment of fibromyalgia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468876/
https://www.ncbi.nlm.nih.gov/pubmed/32784915
http://dx.doi.org/10.3390/nu12082386
work_keys_str_mv AT ramireztejerojorgea hydroxytyrosolasapromisingallyinthetreatmentoffibromyalgia
AT martinezlaraesther hydroxytyrosolasapromisingallyinthetreatmentoffibromyalgia
AT peinadomangeles hydroxytyrosolasapromisingallyinthetreatmentoffibromyalgia
AT delmoralmarialuisa hydroxytyrosolasapromisingallyinthetreatmentoffibromyalgia
AT sileseva hydroxytyrosolasapromisingallyinthetreatmentoffibromyalgia